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The prevalence of Diabetes Mellitus (DM) has increased in recent decades. This study was designed to
determine retinopathy, neuropathy, nephropathy, hypertension and hyperlipidemia and their interde-
pendence in newly diagnosed diabetic patients. In this study, 200 consecutive newly diagnosed patients
were evaluated and screening tests for retinopathy, neuropathy, nephropathy, hypertension and hyper-
lipidemia were undertaken.
The frequency of positive screening tests for hyperlipidemia, hypertension, neuropathy, nephropathy
and retinopathy was found to be 73.5%, 58.5%, 52%, 10%, and 6% respectively.
A significant proportion of newly diagnosed diabetic patients have signs of these chronic complications.
 2009 International Journal of Diabetes Mellitus. Published by Elsevier Ltd.1. Introduction
Diabetes mellitus (DM) is a metabolic disorder resulting from a
defect in insulin secretion and/or insulin action, which results in
hyperglycemia with disturbances of carbohydrate, fat and protein
metabolism [1]. The incidence of DM has increased dramatically
in recent decades, predominantly because of changes in life style,
an increase in the prevalence of obesity and longevity. Current pro-
jections estimate that the number of people with DM will increase
by 50.0% by 2010, and will nearly double by 2025 [2,3].
Type 2 diabetes is a very common disease, characterized by an
asymptomatic phase between the actual onset of diabetic hyper-
glycemia and clinical diagnosis. This phase has been estimated to
last at least 4–7 years, and 30–50% cases of type 2 diabetic patients
remained undiagnosed. This leads to the development of chronic
complications of diabetes, which remain the chief problems in dia-
betic care, and which cause a lack of fitness to work, disability, and
premature death [4,5].
The literature traditionally divides the diverse spectrum of vas-
culopathy associated with diabetes into two main subtypes: firstly,
the diabetes-specific microvascular complications of retinopathy,
nephropathy and neuropathy; and secondly, the atherothrombotic
macrovascular complications of myocardial infarction, hyperten-
sion and peripheral arterial disease [6].ellitus. Published by Elsevier Ltd.
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Many studies [6–8] stress the strong link between the various
complications of diabetes. Andrew J et al. [6] have found a close
association between microvascular and macrovascular complica-
tions of diabetes.
The aim of this study is to determine the prevalence and rela-
tionship between different complications of diabetes in newly
diagnosed Iranian patients.2. Materials and method
In this cross sectional study, 200 consecutive newly diagnosed
patients referred to the Institute of Endocrinology and Metabolism
affiliated to Iran University of Medical Sciences (IUMS) from Octo-
ber to March 2006, were enrolled. The study was approved by the
ethics committee of IUMS. The patients were informed about the
study, and written consent was obtained from them.
The frequency of nephropathy, retinopathy, neuropathy, hyper-
lipidemia and hypertension were evaluated in these patients. The
diagnosis of diabetes is confirmed by fasting plasma glucose, mea-
sured from a venus sample after an overnight fast. Patients having
ketonuria upon presentation were excluded.2.1. Nephropathy
In this study both urine albumin and creatinine were measured.
Albumiuria is defined as urinary albumin–creatinine ratio >
or = 30 mg/g. (microalbuminuria with albumin of 30 to 300 mg/g
and macroalbuminuria with albumin > 300 mg/g) [9]. Renal failure
is defined according to the cut of value of laboratory; creatinine of
(?) more than 1 for women and more than 1.2 for men.pen access under CC BY-NC-ND license.
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To assess the presence of diabetic retinopathy, fundus
examination was performed by an ophthalmologist following
mydriasis of both eyes with tropicamide and phenylephrine eye
drops. Retinopathy was grouped into proliferative and non-
proliferative.
2.3. Neuropathy
Patients fulfilled a questionnaire about their symptoms such as
a feeling of pins and needles, abnormal cold or warm sensations in
their feet, sharp pain, aching pain, or irritation to feet or legs by
bedclothes at night. A modified neuropathy disability score (NDS)
was used to diagnose and quantify the severity of diabetic neurop-
athy on clinical examination [10].
2.4. Lipids
Blood sampling after a 12-hour fasting in patients was per-
formed. Total cholesterol and triglyceride were measured and disl-
ipidemia was defined as cholesterol > 200 or TG > 150.
2.5. Hypertension
Blood pressure was measured in the right arm supported on a
table at heart level with an appropriate cuff to the patient’s arm
girth. We measured BP three times within a one –week interval
and the average of these recordings was considered as their blood
pressure. Those with systolic BP of more than 139 or diastolic BP of
more than 89, or those who were taking antihypertensive medica-
tion, were considered to have hypertension.
2.6. Statistical analyses
Data are presented as a mean, using SPSS software version 15. p
Values of less than 0.05 were considered to be statistically
significant.3. Result
Of 200 newly diagnosed diabetic patients, 52% were men and
48% women. The Mean ± SD age at presentation was 52.39 ±
10.03 years. The prevalence of nephropathy was 10%, including
13 patients (65%) with microalbuminuria, 4 patients (20%) with
macroalbuminuria, and 3 patients (15%) with renal failure. Reti-
nopathy was recorded in 12 patients (6%); 7 patients (58.3%) had
proliferative, 5 patients (41.6%) had non-proliferative. Symptom-
atic neuropathy was found in 104 patients (52%). Among the pa-
tients with cardiovascular problems, 147 patients (73.5%) had
hyperlipidemia, 37 (25.2%) showed hypercholesterolaemia, 49
(33.3%) revealed hypertriglyceridaemia and 61 patients (41/5%)
had both hypercholesterolaemia and hypertriglyceridaemia. The
prevalence of hypertension was 58.50%.
There was a statistically significant relationship between the
following variables:
(1) Age and hypertension (p < 0.001): The average age of hyper-
tensive patients was 6.2 years higher than non-hypertensive
patients.
(2) Age and the form of nephropathy (p < 0.01): There was no
statistically significant difference between age and the prev-
alence of nephropathy, but renal failure was more common
in older patients, so that the mean age of patients with renal
failure was 71.33 ± 14.43 years, whereas the mean age ofpatients with macro and microalbuminuria was 55.5 ± 10.5
and 42 ± 11.1 years respectively.
(3) Retinopathy and hypertension (p < 0.003): The prevalence of
retinopathy increased statistically with the presence of
hypertension, so that 33.3% of patients with retinopathy
were also hypertensive.
(4) Retinopathy and neuropathy (p < 0.01): 77.7% of patients
with proliferative retinopathy had neuropathy.
(5) Retinopathy and nephropathy (p < 0.01): The prevalence of
nephropathy was 86% among patients with retinopathy and
its probability increased with the severity of retinopathy.4. Discussion
Diabetes Mellitus is a multifactorial disease, associated with a
number of microvascular (retinopathy, neuropathy and nephropa-
thy) and macrovascular (ischemic heart disease, cerebrovascular
disease and peripheral vascular diseases) complications [11]. This
metabolic disease is one of the most common endocrine disorders
affecting almost 6% of the world’s population [12]. The prevalence
of DM in Iran was estimated at 5.5% in a population-based study
conducted by Azimi-nezhad et al. [13].
Type 2 DM is likely to remain undiagnosed for (many?)years.
The gap between the onset of the disease and clinical diagnosis
of diabetes leads to the development of these chronic complica-
tions, which are the leading causes of premature mortality among
diabetic patients [14].
In this study, which is one of the first studies in this regards in
Iran, we assessed the prevalence of micro and macro vascular com-
plications of DM in 200 newly diagnosed diabetic patients.
Nephropathy was reported in 10%, neuropathy in 52%, retinopathy
in 6%, hypertension in 58.5% and hyperlipidemia in 73.5% of the pa-
tients. There are further studies that assess the prevalence of these
chronic complications; Harrzallah F et al. [15] found neuropathy in
24%, nephropathy in 13%, retinopathy 8% and hypertension in 22%
of diabetic patients. In another study conducted by Weerasuriya
[16] in Sri Lanakan diabetic patients, neuropathy was present in
25.1 %, nephropathy in 29%, retinopathy in 15% and hypertension
in 23%. Considering the prevalence of these chronic complications
at the time of diagnosis in different studies, appropriate screening
procedures for diabetic patients is strongly recommended.
Microvascular and macrovascular complications frequently
coexist. It is well recognized that vascular complications in a given
tissue are often accompanied by evidence of pathology in other
vascular territories [6]. There are several studies [7,8,17] that dem-
onstrate a concordance between chronic complications of DM. This
study found nephropathy in 86% of diabetic patients with retinop-
athy. Osterby et al. [17], also found a strong concordance between
retinopathy and the structural parameters of diabetic nephropathy.
Our study also showed that the prevalence of retinopathy in-
creased with hypertension, since hypertension coexisted in 33.5%
of patients with retinopathy. This data is in agreement with the
findings of Matthews et al. [18], which showed high blood pressure
to be detrimental to each aspect of diabetic retinopathy, and that a
rigid blood pressure control policy reduces the risk of clinical com-
plications from diabetic eye disease.
Hideharu and Hidetoshi [19], similarly, concluded that hyper-
tension is a risk factor for the progression of diabetic retinopathy,
mostly because hyperglycaemia in diabetic patients impairs the
regulation of retinal perfusion, leading to increased susceptibility
to injury by systemic hypertension.
In this study, 77.7% of diabetic patients with proliferative reti-
nopathy had neuropathy. Similarly, in Zander et al. study [20], pro-
liferative retinopathy was found to be correlated with somatic and
autonomic neuropathy in diabetic patients.
Fig. 1. The prevalence of chronic complication of type 2 Diabetes Mellitus in 200
newly diagnosed patients.
I. Heydari et al. / International Journal of Diabetes Mellitus 2 (2010) 61–63 63Furthermore, the prevalence of hypertension in diabetic indi-
viduals demonstrated a highly significant trend with age [21], as
in this study, the average age of hypertensive patients was
6.2 years higher than for non-hypertensive ones.
In conclusion, there seems to be a strong concordance between
chronic complications of diabetes mellitus. Thus, thorough screen-
ing of these complications in newly diagnosed diabetic patients is
strongly recommended (see Fig. 1).
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